supp.fit

Soy Isoflavones: study protocols

263 study groups say how much Soy Isoflavones participants took a day. These are the doses the studies gave. They are not a recommendation.

Soy Isoflavones: what the research found →

Dose per serving from products

156 products in our catalogue print how much Soy Isoflavones a serving holds.

Most common: 25 mg to 50 mg, 39% of 156 products.

Dose per servingProducts
2.5 mg or less
7
2.5 mg to 5 mg
3
5 mg to 10 mg
12
10 mg to 25 mg
31
25 mg to 50 mg
61
50 mg to 100 mg
34
100 mg to 250 mg
7
over 250 mg
1

Dose per serving from research

251 study groups in 183 studies say how much Soy Isoflavones participants took a day.

These are the doses the studies gave. They are not a recommendation.

Most common: 50 mg to 100 mg, 44% of 251 study groups.

Daily doseStudy groups
5 mg or less
7
5 mg to 10 mg
9
10 mg to 25 mg
4
25 mg to 50 mg
43
50 mg to 100 mg
111
100 mg to 250 mg
60
250 mg to 500 mg
3
500 mg to 1 g
2
over 1 g
12

Commonly used together

109 of 263 study groups took Soy Isoflavones with something else. Shown: what 3 or more different studies gave.

What was given together, not what works together.

Taken withStudy groups
Soy Protein
29
Calcium
24
soy protein isolate
16
Vitamin D
13
Isolated soy protein
7
Probiotics
4
Fiber
3
Resveratrol
3
prenatal vitamin (Rugby Prenavite Prenatal Formula)
3

263 study groups

Study
Endometrial effects of long-term treatment with phytoestrogens: a randomized, double-blind, placebo-controlled study
2004 · group A (soy tablets) · Postmenopausal healthy women with an intact uterus
150 mg5 years179
Effects of soy protein isolate consumption on prostate cancer biomarkers in men with HGPIN, ASAP, and low-grade prostate cancer
2008 · Soy protein (SPI+) · Men at high risk of prostate cancer or with HGPIN, ASAP, or low-grade prostate cancer
107 mg26 weeks—
Effects of soy protein isolate consumption on prostate cancer biomarkers in men with HGPIN, ASAP, and low-grade prostate cancer
2008 · Alcohol-washed soy protein (SPI-) · Men at high risk of prostate cancer or with HGPIN, ASAP, or low-grade prostate cancer
6 mg26 weeks—
Associations between urine excretion of isoflavonoids and cognition in postmenopausal women in the Women's Isoflavone Soy Health clinical trial
2014 · daily ISP · healthy postmenopausal women aged 45–92 years
91 mg913 days150
Soy Isoflavones for Reducing Bone Loss Study: effects of a 3-year trial on hormones, adverse events, and endometrial thickness in postmenopausal women
2015 · 80 mg isoflavones · Healthy postmenopausal women aged 45.8–65.0 years, selected for at-risk bone mineral density and without diagnosed chronic disease
80 mg3 years77
Soy Isoflavones for Reducing Bone Loss Study: effects of a 3-year trial on hormones, adverse events, and endometrial thickness in postmenopausal women
2015 · 120 mg isoflavones · Healthy postmenopausal women aged 45.8–65.0 years, selected for at-risk bone mineral density and without diagnosed chronic disease
120 mg3 years73
[Effect of milk product with soy isoflavones on quality of life and bone metabolism in postmenopausal Spanish women: randomized trial]
2012 · Group S · Postmenopausal Spanish women; age range and health conditions not specified
50 mg1 year48
Effect of soy isoflavones supplementation on migraine characteristics, mental status and calcitonin gene-related peptide (CGRP) levels in women with migraine: results of randomised controlled trial
2022 · soy isoflavones group · Adult women over 18 years and before menopause/perimenopause, diagnosed with migraine
50 mg8 weeks44
Benefits of soy isoflavone therapeutic regimen on menopausal symptoms
2002 · isoflavone · postmenopausal women
100 mg120 days40
Randomized clinical trial comparing conjugated equine estrogens and isoflavones in postmenopausal women: a pilot study
2006 · isoflavone · Postmenopausal women
120 mg26 weeks40
Efficacy and safety of a soy isoflavone extract in postmenopausal women: a randomized, double-blind, and placebo-controlled study
2007 · soy isoflavone group · postmenopausal women with at least 5 hot flush episodes per day; mean age 55.1 years
100 mg300 days40
Consumption of a soy drink has no effect on cognitive function but may alleviate vasomotor symptoms in post-menopausal women; a randomised trial
2020 · Low-dose group · Apparently healthy post-menopausal women, within 1–7 years since their last menstrual period
10 mg12 weeks39
Consumption of a soy drink has no effect on cognitive function but may alleviate vasomotor symptoms in post-menopausal women; a randomised trial
2020 · Medium-dose group · Apparently healthy post-menopausal women, within 1–7 years since their last menstrual period
35 mg12 weeks38
Consumption of a soy drink has no effect on cognitive function but may alleviate vasomotor symptoms in post-menopausal women; a randomised trial
2020 · High-dose group · Apparently healthy post-menopausal women, within 1–7 years since their last menstrual period
60 mg12 weeks38
Effects of Fermented Soy on Cognition in Older Adults: Outcomes of a Randomized, Controlled Trial
2025 · fermented soy · Healthy ambulatory men and postmenopausal women aged 65 years and older
36.3 mg12 weeks33
Cognitive Effects of Soy Isoflavones in Patients with Alzheimer's Disease
2015 · soy isoflavone group · men and postmenopausal women over age 60 with Alzheimer’s disease
100 mg26 weeks32
Soy germ isoflavones improve menopausal symptoms but have no effect on blood lipids in early postmenopausal Chinese women: a randomized placebo-controlled trial
2012 · 84 mg soy germ isoflavones · Chinese women aged 45–60 years in early postmenopause
84 mg24 weeks30
Soy germ isoflavones improve menopausal symptoms but have no effect on blood lipids in early postmenopausal Chinese women: a randomized placebo-controlled trial
2012 · 126 mg soy germ isoflavones · Chinese women aged 45–60 years in early postmenopause
126 mg24 weeks30
Supplementation of soy isoflavones improved sex hormones, blood pressure, and postmenopausal symptoms
2015 · experimental group · Postmenopausal women
54 mg8 weeks30
Polyunsaturated fatty acids (PUFAs) might reduce hot flushes: an indication from two controlled trials on soy isoflavones alone and with a PUFA supplement
2005 · Study A: soy isoflavone extract · Postmenopausal women with more than five troublesome hot flushes per day
60 mg12 weeks29
Isoflavones and cognitive function in older women: the SOy and Postmenopausal Health In Aging (SOPHIA) Study
2003 · active treatment · Postmenopausal women aged 55–74 in good health, postmenopausal for at least 2 years, and not using estrogen replacement therapy
110 mg26 weeks27
Benefits of soy germ isoflavones in postmenopausal women with contraindication for conventional hormone replacement therapy
2004 · soy germ isoflavones · Postmenopausal women with hot flushes and contraindications for conventional hormone replacement therapy
60 mg26 weeks25
Effect of soy isoflavone protein and soy lecithin on endothelial function in healthy postmenopausal women
2007 · soy isoflavone protein and placebo lecithin · Healthy postmenopausal women, mean age 61 years
25 g4 weeks25
Co-Administration of Soy Isoflavones and Vitamin D in Management of Irritable Bowel Disease
2016 · Soy isoflavones and placebo of vitamin D (S+P) · Women aged 18–75 with irritable bowel syndrome (IBS)
20 mg6 weeks25
Isoflavone-rich soy protein prevents loss of hip lean mass but does not prevent the shift in regional fat distribution in perimenopausal women
2003 · SPI+ · Perimenopausal women; age range and specific conditions not stated
40 g24 weeks24
Effect of consumption of soy isoflavones on behavioural, somatic and affective symptoms in women with premenstrual syndrome
2005 · ISP containing soy isoflavones · Women aged 18–35 years with prospectively confirmed premenstrual syndrome and BMI 19–30 kg/m²
68 mg—23
A meal enriched with soy isoflavones increases nitric oxide-mediated vasodilation in healthy postmenopausal women
2008 · isoflavone-enriched meal (ISO) · Healthy postmenopausal women
80 mg1 day22
Oral intake of soy isoflavone aglycone improves the aged skin of adult women
2007 · test food group · Women in their late 30s and early 40s with aged skin
40 mg12 weeks13
Genistein Supplementation and Cardiac Function in Postmenopausal Women with Metabolic Syndrome: Results from a Pilot Strain-Echo Study
2017 · genistein group · Postmenopausal women with type 2 diabetes and metabolic syndrome; age 55 years (median reported)
54 mg1 year11
Vasomotor symptom relief by soy isoflavone extract tablets in postmenopausal women: a multicenter, double-blind, randomized, placebo-controlled study
2000 · soy isoflavone extract · Postmenopausal women, mean age 55 years, experiencing five or more hot flushes per day
50 mg12 weeks—
Effects of a standardized soy extract on hot flushes: a multicenter, double-blind, randomized, placebo-controlled study
2002 · soy isoflavone extract group · Menopausal women in natural or surgical menopause with at least seven hot flushes per day; age not stated
70 mg120 days—
Isoflavones improve vascular reactivity in post-menopausal women with hypercholesterolemia
2004 · isoflavone group · post-menopausal women with hypercholesterolemia who were not taking estrogen replacement therapy
90 mg6 weeks—
Effects of soy isoflavones on menopausal neurovegetative symptoms
2004 · group A · postmenopausal women
50 mg90 days—
Effects of soy isoflavones on menopausal neurovegetative symptoms
2004 · group B · postmenopausal women
75 mg90 days—
Cognitive improvement after 6 weeks of soy supplements in postmenopausal women is limited to frontal lobe function
2005 · soy supplement group · Postmenopausal women aged 51–66 years not taking other forms of hormone therapy
60 mg6 weeks—
Effect of intestinal production of equol on menopausal symptoms in women treated with soy isoflavones
2008 · equol-producing (EP) group · Healthy menopausal women who produced equol
135 mg26 weeks—
Effect of intestinal production of equol on menopausal symptoms in women treated with soy isoflavones
2008 · non-equol-producing (non-EP) group · Healthy menopausal women who did not produce equol
135 mg26 weeks—
Soy extract phytoestrogens with high dose of isoflavones for menopausal symptoms
2009 · isoflavones arm · Women aged 40–65 years with at least five moderate-to-severe hot flushes in the prior 7 days and no menstruation for at least 6 months
80 mg12 weeks—
[Effect of soy isoflavones on peri-menopausal symptom and estrogen]
2010 · SI group · Women with peri-menopausal symptoms; age not stated
120 mg8 weeks—
The effect of dietary soy supplementation compared to estrogen and placebo on menopausal symptoms: a randomized controlled trial
2010 · dietary soy supplementation · Healthy, symptomatic postmenopausal women aged 40–60 years
90 mg16 weeks—
Isoflavones in treating watchful waiting benign prostate hyperplasia: a double-blinded, randomized controlled trial
2012 · intervention · men with benign prostate hyperplasia (BPH) and lower urinary tract symptoms
40 mg1 year—
Effects of standardized phytoestrogen on Taiwanese menopausal women
2012 · 35 mg soy extract group · Healthy Taiwanese postmenopausal women after natural menopause
35 mg24 weeks—
Effects of standardized phytoestrogen on Taiwanese menopausal women
2012 · 70 mg soy extract group · Healthy Taiwanese postmenopausal women after natural menopause
70 mg24 weeks—
Effects of a soy-based dietary supplement compared with low-dose hormone therapy on the urogenital system: a randomized, double-blind, controlled clinical trial
2015 · soy dietary supplement group · Healthy postmenopausal women aged 40 to 60 years
90 mg16 weeks—
Acupuncture or phy(F)itoestrogens vs. (E)strogen plus progestin on menopausal symptoms. A randomized study
2019 · soy isoflavones · postmenopausal women with hot flushes
150 mg90 days—
Soy isoflavones decrease fibroglandular breast tissue measured by magnetic resonance imaging in premenopausal women: A 2-year randomized double-blind placebo controlled clinical trial
2022 · isoflavone group · Healthy premenopausal women aged 30–42 years with monthly menstrual cycles
137 mg2 years99
Impact of a soy drink on climacteric symptoms: an open-label, crossover, randomized clinical trial
2016 · ViveSoy® phase · Peri- or postmenopausal women aged 45 years or older with climacteric symptoms
50 mg12 weeks90
Nonhormonal management of postmenopausal women: effects of a red clover based isoflavones supplementation on climacteric syndrome and cardiovascular risk serum profile
2013 · phytoestrogens tablets · healthy postmenopausal women
19.2 mg26 weeks75
Soy protein supplementation in men following radical prostatectomy: a 2-year randomized, placebo-controlled clinical trial
2021 · soy · Men aged 44–75 at risk of cancer recurrence following radical prostatectomy
41 mg2 years50
Polyunsaturated fatty acids (PUFAs) might reduce hot flushes: an indication from two controlled trials on soy isoflavones alone and with a PUFA supplement
2005 · Study B: soy isoflavone extract with PUFA supplement · Postmenopausal women with more than five troublesome hot flushes per day
60 mg12 weeks28
Effect of soy isoflavone protein and soy lecithin on endothelial function in healthy postmenopausal women
2007 · soy isoflavone protein and soy lecithin · Healthy postmenopausal women, mean age 61 years
25 g4 weeks25
Co-Administration of Soy Isoflavones and Vitamin D in Management of Irritable Bowel Disease
2016 · Soy isoflavones and vitamin D (S+D) · Women aged 18–75 with irritable bowel syndrome (IBS)
20 mg6 weeks25
Longer-term soy nut consumption improves vascular function and cardiometabolic risk markers in older adults: Results of a randomized, controlled cross-over trial
2022 · soy nut intervention · Healthy men and women aged 60–70 years with BMI 20–30 kg/m²
174 mg16 weeks23
Soy Protein Containing Isoflavones Improves Facial Signs of Photoaging and Skin Hydration in Postmenopausal Women: Results of a Prospective Randomized Double-Blind Controlled Trial
2023 · SPII (soy protein containing isoflavones) · Healthy postmenopausal women aged 50–70 with Fitzpatrick skin types I–III
50 mg24 weeks23
Short-term supplementation with a specific combination of dietary polyphenols increases energy expenditure and alters substrate metabolism in overweight subjects
2014 · E+R+S · Healthy overweight women and men, mean age 35 years
80 mg3 days18
Metabolic effects of soy supplementation in postmenopausal Caucasian and African American women: a randomized, placebo-controlled trial
2010 · soy supplement · Postmenopausal women aged 45–60 with obesity (BMI 30–40 kg/m²), without diabetes; Caucasian and African American participants
160 mg90 days17
Influence of a new botanical combination on quality of life in menopausal Spanish women: Results of a randomized, placebo-controlled pilot study
2021 · Herbal extract · Healthy Spanish women aged 45–55 with menopause onset no more than five years earlier and initial Cervantes Scale score ≥53
200 mg8 weeks17
Effect of a daily supplement of soy protein on body composition and insulin secretion in postmenopausal women
2007 · Soy shake · Postmenopausal women aged 55.6 ± 1.4 years with BMI 30.5 ± 0.8 kg/m² and no diabetes
160 mg90 days9
Randomized, controlled trial of phytoestrogen in the prophylactic treatment of menstrual migraine
2002 · phytoestrogen preparation · Women with menstrually associated migraine
60 mg24 weeks—
Soy protein with isoflavones has favorable effects on endothelial function that are independent of lipid and antioxidant effects in healthy postmenopausal women
2003 · Isolated soy protein with isoflavones · Healthy postmenopausal women
107 mg6 weeks—
Soy protein with isoflavones has favorable effects on endothelial function that are independent of lipid and antioxidant effects in healthy postmenopausal women
2003 · Ethanol-washed isolated soy protein with trace isoflavones · Healthy postmenopausal women
2 mg6 weeks—
The association between soy nut consumption and decreased menopausal symptoms
2007 · TLC diet plus soy nuts · Healthy postmenopausal women
101 mg8 weeks—
A mild favorable effect of soy protein with isoflavones on body composition--a 6-month double-blind randomized placebo-controlled trial among Chinese postmenopausal women
2010 · Soy group · Chinese postmenopausal women with mild hyperglycemia; age range not reported
100 mg26 weeks—
Soy isoflavone supplementation for breast cancer risk reduction: a randomized phase II trial
2012 · mixed soy isoflavones · Women aged 25–55 at increased risk for breast cancer or with a history of unilateral minimal-risk breast cancer; healthy, non-pregnant and non-lactating
235 mg26 weeks—
Long-term soy isoflavone supplementation and cognition in women: a randomized, controlled trial
2012 · isoflavone group · Healthy postmenopausal women aged 45–92 years
91 mg913 days—
Influence of equol and resveratrol supplementation on health-related quality of life in menopausal women: A randomized, placebo-controlled study
2017 · equol and resveratrol group · Healthy recently menopausal women aged 50–55 years with hot flashes, anxiety and depressive symptoms
210 mg12 weeks—
Isoflavone soy protein supplementation and atherosclerosis progression in healthy postmenopausal women: a randomized controlled trial
2011 · ISP · Postmenopausal women without pre-existing cardiovascular disease; age range not specified
25 g3 years175
Daidzein and genistein have differential effects in decreasing whole body bone mineral density but had no effect on hip and spine density in premenopausal women: A 2-year randomized, double-blind, placebo-controlled study
2019 · isoflavone group · Healthy premenopausal women aged 30–42 years with regular monthly menstrual cycles
137 mg2 years99
Soy isoflavone tablets reduce osteoporosis risk factors and obesity in middle-aged Japanese women
2004 · ISO group · Healthy Japanese pre- and postmenopausal women
100 mg24 weeks34
Soy isoflavones attenuate bone loss in early postmenopausal Chinese women : a single-blind randomized, placebo-controlled trial
2006 · 84 mg isoflavones group · Chinese women aged 45–60 years in early postmenopause; non-obese, with high Kuppermann Scale
84 mg26 weeks30
Soy isoflavones attenuate bone loss in early postmenopausal Chinese women : a single-blind randomized, placebo-controlled trial
2006 · 126 mg isoflavones group · Chinese women aged 45–60 years in early postmenopause; non-obese, with high Kuppermann Scale
126 mg26 weeks30
Soy protein reduces serum LDL cholesterol and the LDL cholesterol:HDL cholesterol and apolipoprotein B:apolipoprotein A-I ratios in adults with type 2 diabetes
2009 · soy protein isolate (SPI) · Adults with diet-controlled type 2 diabetes
80 mg57 days29
A Non-Probiotic Fermented Soy Product Reduces Total and LDL Cholesterol: A Randomized Controlled Crossover Trial
2021 · fermented soy powder · Adult men and women aged 30–75 years with at least two cardiovascular disease risk factors
25 g12 weeks27
Soymilk or progesterone for prevention of bone loss--a 2 year randomized, placebo-controlled trial
2004 · soy+ · Postmenopausal Caucasian women with established osteoporosis or at least 3 risk factors for osteoporosis
76 mg2 years23
Soymilk or progesterone for prevention of bone loss--a 2 year randomized, placebo-controlled trial
2004 · combination of soy+ and TDP+ · Postmenopausal Caucasian women with established osteoporosis or at least 3 risk factors for osteoporosis
76 mg2 years22
Blood pressure and cardiovascular risk factors in women treated for climacteric symptoms with acupuncture, phytoestrogens, or hormones
2020 · phytoestrogens · Women reporting climacteric symptoms
150 mg90 days22
Soy isoflavones improve plasma lipids in normocholesterolemic and mildly hypercholesterolemic postmenopausal women
2001 · control · Postmenopausal women with normocholesterolemia or mild hypercholesterolemia
7.1 mg93 days18
Soy isoflavones improve plasma lipids in normocholesterolemic and mildly hypercholesterolemic postmenopausal women
2001 · low isoflavone · Postmenopausal women with normocholesterolemia or mild hypercholesterolemia
65 mg93 days18
Soy isoflavones improve plasma lipids in normocholesterolemic and mildly hypercholesterolemic postmenopausal women
2001 · high isoflavone · Postmenopausal women with normocholesterolemia or mild hypercholesterolemia
132 mg93 days18
Soy isoflavones improve plasma lipids in normocholesterolemic, premenopausal women
2000 · control · Healthy, normocholesterolemic, premenopausal women
10 mg——
Soy isoflavones improve plasma lipids in normocholesterolemic, premenopausal women
2000 · low-isoflavone intake · Healthy, normocholesterolemic, premenopausal women
64.7 mg——
Soy isoflavones improve plasma lipids in normocholesterolemic, premenopausal women
2000 · high-isoflavone intake · Healthy, normocholesterolemic, premenopausal women
129 mg——
Soy protein and bone mineral density in older men and women: a randomized trial
2006 · +ISO · Men and women aged 50–80 years
83 mg1 year—
Possible role of equol status in the effects of isoflavone on bone and fat mass in postmenopausal Japanese women: a double-blind, randomized, controlled trial
2007 · isoflavone group · Early postmenopausal Japanese women, classified by equol-producer phenotype
75 mg1 year—
Equol status and blood lipid profile in hyperlipidemia after consumption of diets containing soy foods
2012 · Soy foods with high-normal isoflavones · Hypercholesterolemic men and postmenopausal women
73 mg30 days—
Equol status and blood lipid profile in hyperlipidemia after consumption of diets containing soy foods
2012 · Soy foods with low isoflavones · Hypercholesterolemic men and postmenopausal women
10 mg30 days—
Soy proteins and isoflavones reduce interleukin-6 but not serum lipids in older women: a randomized controlled trial
2013 · control protein + isoflavone tablets (CPI) · Postmenopausal women; mean age not stated; generally healthy, late postmenopausal women
105 mg1 year—
Whole soy, but not purified daidzein, had a favorable effect on improvement of cardiovascular risks: a 6-month randomized, double-blind, and placebo-controlled trial in equol-producing postmenopausal women
2014 · daidzein group · Prehypertensive postmenopausal women who were equol producers
63 mg26 weeks—
Wrinkle reduction in post-menopausal women consuming a novel oral supplement: a double-blind placebo-controlled randomized study
2014 · Test group 1 · Healthy, non-smoking post-menopausal women, skin types I–III, not receiving HRT and with BMI 18–33 kg/m²
70 mg14 weeks55
Wrinkle reduction in post-menopausal women consuming a novel oral supplement: a double-blind placebo-controlled randomized study
2014 · Test group 2 · Healthy, non-smoking post-menopausal women, skin types I–III, not receiving HRT and with BMI 18–33 kg/m²
40 mg14 weeks55
Soy isoflavones, lactobacilli, Magnolia bark extract, vitamin D3 and calcium. Controlled clinical study in menopause
2006 · ES (Estromineral serena) · Symptomatic menopausal women with sleep or mood alterations
60 mg24 weeks44
The soy isoflavones for reducing bone loss study: 3-yr effects on pQCT bone mineral density and strength measures in postmenopausal women
2011 · 80 mg of isoflavones · Postmenopausal women aged 46.1–63.1 years, 0.8–7.88 years since last menstrual period, without diagnosed chronic disease
80 mg3 years—
The soy isoflavones for reducing bone loss study: 3-yr effects on pQCT bone mineral density and strength measures in postmenopausal women
2011 · 120 mg of isoflavones · Postmenopausal women aged 46.1–63.1 years, 0.8–7.88 years since last menstrual period, without diagnosed chronic disease
120 mg3 years—
Effects of the phytoestrogen genistein on bone metabolism in osteopenic postmenopausal women: a randomized trial
2007 · genistein · Postmenopausal women with osteopenia and femoral-neck BMD below 0.795 g/cm2
54 mg2 years198
Effect of exercise training combined with isoflavone supplementation on bone and lipids in postmenopausal women: a randomized clinical trial
2013 · Isoflavone supplementation (Iso) · Postmenopausal women; age and other conditions not specified
165 mg2 years90
Effect of exercise training combined with isoflavone supplementation on bone and lipids in postmenopausal women: a randomized clinical trial
2013 · Combined exercise and isoflavone (ExIso) · Postmenopausal women; age and other conditions not specified
165 mg2 years87
Effect of soy nuts on blood pressure and lipid levels in hypertensive, prehypertensive, and normotensive postmenopausal women
2007 · TLC diet plus soy nuts · Healthy postmenopausal women, including hypertensive, prehypertensive, and normotensive women
101 mg8 weeks60
Effect of soy nuts and equol status on blood pressure, lipids and inflammation in postmenopausal women stratified by metabolic syndrome status
2015 · TLC diet with soy nuts · Healthy postmenopausal women, with and without metabolic syndrome; no atherosclerosis or diabetes
101 mg8 weeks60
Equol and Resveratrol Improve Bone Turnover Biomarkers in Postmenopausal Women: A Clinical Trial
2023 · equol/resveratrol combination · Caucasian postmenopausal women aged 50–55 with menopausal complaints and BMI 20 to <25 kg/m²
80 mg1 year38
Effect of soy protein varying in isoflavone content on serum lipids in healthy young men
2006 · low-isoflavone soy protein isolate (low-iso SPI) · Healthy young men; mean age 27.9 ± 5.7 years
1.64 mg57 days35
Effect of soy protein varying in isoflavone content on serum lipids in healthy young men
2006 · high-isoflavone SPI (high-iso SPI) · Healthy young men; mean age 27.9 ± 5.7 years
61.7 mg57 days35
The effect of soy protein with or without isoflavones relative to milk protein on plasma lipids in hypercholesterolemic postmenopausal women
2001 · Soy+ group · Postmenopausal women with moderate hypercholesterolemia
80 mg12 weeks31
[Relationship between estrogen receptor gene Px haplotype and the effect of calcium and soy isoflavone supplementation on bone mineral density of Chinese postmenopausal women]
2008 · Ca + soy isoflavone group · Chinese postmenopausal women aged 45–65 with baseline BMD T score < -1.5
100 mg1 year26
Isoflavone-rich soy protein isolate attenuates bone loss in the lumbar spine of perimenopausal women
2000 · SPI+ (isoflavone-rich soy) · Perimenopausal women
80.4 mg24 weeks24
Beneficial effects of a soy-based dietary supplement on lipid levels and cardiovascular risk markers in type 2 diabetic subjects
2001 · Abalon · Adults with type 2 diabetes
165 mg6 weeks—
Dietary soy has both beneficial and potentially adverse cardiovascular effects: a placebo-controlled study in men and postmenopausal women
2001 · soy protein isolate group · Healthy men and postmenopausal women aged 50–75 years
118 mg90 days—
Effects of soy supplementation on blood lipids and arterial function in hypercholesterolaemic subjects
2005 · soy supplement (Abalon) · Hypercholesterolaemic but otherwise healthy adults; age range and sex not stated
100 mg24 weeks—
[The effects of phytoestrogen on blood pressure and lipids in healthy volunteers]
2006 · soy protein isolate group · Healthy men and post-menopausal women aged 50–76 years
118 mg90 days—
Soy isoflavone supplementation and bone mineral density in menopausal women: a 2-y multicenter clinical trial
2009 · 80 mg soy isoflavones group · Postmenopausal women; described as healthy
80 mg2 years—
Soy isoflavone supplementation and bone mineral density in menopausal women: a 2-y multicenter clinical trial
2009 · 120 mg soy isoflavones group · Postmenopausal women; described as healthy
120 mg2 years—
The effect on the blood lipid profile of soy foods combined with a prebiotic: a randomized controlled trial
2010 · soy food-containing diet · Hyperlipidemic adults; mean age 58 ± 7 years; 11 men and 12 women
61 mg4 weeks—
The effect on the blood lipid profile of soy foods combined with a prebiotic: a randomized controlled trial
2010 · soy food-containing diet with prebiotic · Hyperlipidemic adults; mean age 58 ± 7 years; 11 men and 12 women
61 mg4 weeks—
Effect of soy protein and isoflavones on blood pressure and endothelial cytokines: a 6-month randomized controlled trial among postmenopausal women
2013 · Soy group · Postmenopausal Chinese women with mild hyperglycemia; subgroup analysis included women with prehypertension or hypertension
100 mg26 weeks—
Effect of soy protein and isoflavones on blood pressure and endothelial cytokines: a 6-month randomized controlled trial among postmenopausal women
2013 · Iso group · Postmenopausal Chinese women with mild hyperglycemia
100 mg26 weeks—
Soy proteins and isoflavones reduce interleukin-6 but not serum lipids in older women: a randomized controlled trial
2013 · soy protein + isoflavone tablets (SPI) · Postmenopausal women; mean age not stated; generally healthy, late postmenopausal women
105 mg1 year—
Soy isoflavones improve cardiovascular disease risk markers in women during the early menopause
2018 · soy protein with isoflavones (SPI) · Women in the early menopause, mean age 55 years
66 mg26 weeks—
Soy isoflavones interact with calcium and contribute to blood pressure homeostasis in women: a randomized, double-blind, placebo controlled trial
2020 · Isoflavone group · Healthy premenopausal women aged 30–42 years
137 mg2 years—
Food matrix and isoflavones bioavailability in early post menopausal women: a European clinical study
2008 · IF-enriched biscuits · Healthy postmenopausal women aged 49–60 years
100 mg3 days42
Food matrix and isoflavones bioavailability in early post menopausal women: a European clinical study
2008 · IF-enriched cereal bars · Healthy postmenopausal women aged 49–60 years
100 mg3 days42
Mothers' Consumption of Soy Drink But Not Black Tea Increases the Flavonoid Content of Term Breast Milk: A Pilot Randomized, Controlled Intervention Study
2017 · soy drink · Healthy nursing women
12 mg6 days18
Prostatic soy isoflavone concentrations exceed serum levels after dietary supplementation
2009 · isoflavone group · Men with newly diagnosed, clinically localized prostate cancer undergoing radical prostatectomy
82 mg2 weeks14
Beneficial effects of soybean isoflavone supplementation on bone metabolism and serum lipids in postmenopausal japanese women: a four-week study
2002 · isoflavone group · Healthy perimenopausal women
61.8 mg4 weeks12
Pharmacokinetics of isoflavones, daidzein and genistein, after ingestion of soy beverage compared with soy extract capsules in postmenopausal Thai women
2005 · Soy beverage · Postmenopausal Thai women aged 46–61 years in good health
15 g1 day12
Higher bioavailability of isoflavones after a single ingestion of a soya-based supplement than a soya-based food in young healthy males
2008 · soya-based supplement · Young healthy males
35 mg1 day12
Orally administered isoflavones are present as glucuronides in the human prostate
2008 · soy extract supplementation · Men with benign prostatic hyperplasia undergoing prostate surgery; age not reported
113 mg3 days12
Effects of isoflavone supplements vs. soy foods on blood concentrations of genistein and daidzein in adults
2009 · one Novasoy tablet three times/day · Generally healthy adults aged 28–74; five postmenopausal women, four premenopausal women, and four men enrolled
144 mg7 days12
Effects of isoflavone supplements vs. soy foods on blood concentrations of genistein and daidzein in adults
2009 · two Novasoy tablets three times/day · Generally healthy adults aged 28–74; five postmenopausal women, four premenopausal women, and four men enrolled
144 mg7 days12
Influence of ethnic origin (Asian v. Caucasian) and background diet on the bioavailability of dietary isoflavones
2009 · Asian participants under the Western diet · Healthy young Asian adults; non-equol producers
46 mg10 days12
Influence of ethnic origin (Asian v. Caucasian) and background diet on the bioavailability of dietary isoflavones
2009 · Asian participants under the Asian diet · Healthy young Asian adults; non-equol producers
46 mg10 days12
Influence of ethnic origin (Asian v. Caucasian) and background diet on the bioavailability of dietary isoflavones
2009 · Caucasian participants under the Western diet · Healthy young male Caucasian adults; non-equol producers
46 mg10 days12
Plasma phytoestrogens are not altered by probiotic consumption in postmenopausal women with and without a history of breast cancer
2004 · soy protein (S) · Postmenopausal women, including breast cancer survivors and controls
26.6 g6 weeks—
Influence of 10 wk of soy consumption on plasma concentrations and excretion of isoflavonoids and on gut microflora metabolism in healthy adults
2004 · high-soy diet · Healthy young adults; age range and sex breakdown not reported
104 mg10 weeks—
Influence of 10 wk of soy consumption on plasma concentrations and excretion of isoflavonoids and on gut microflora metabolism in healthy adults
2004 · low-soy diet · Healthy young adults; age range and sex breakdown not reported
540 mcg10 weeks—
Bioavailability of isoflavone phytoestrogens in postmenopausal women consuming soya milk fermented with probiotic bifidobacteria
2005 · Non-fermented soya milk, 80 mg isoflavone/200 ml · Postmenopausal women
240 mg2 weeks—
Urinary estrogen metabolites during a randomized soy trial
2012 · high-soy diet · Non-lactating premenopausal women of diverse ethnicities; no diagnosed condition stated
50 mg26 weeks82
Effect of soy nuts on adhesion molecules and markers of inflammation in hypertensive and normotensive postmenopausal women
2008 · TLC diet with soy nuts replacing non-soy protein · Postmenopausal women, mean ages 53.5 years (normotensive) and 58.3 years (hypertensive); healthy and without clinical atherosclerosis or diabetes
101 mg8 weeks60
Short-term soy isoflavone intervention in patients with localized prostate cancer: a randomized, double-blind, placebo-controlled trial
2013 · soy isoflavone · Men with localized prostate cancer, clinical stage T1 or T2, scheduled to undergo prostatectomy
51 mg6 weeks42
Effects of a high dose, aglycone-rich soy extract on prostate-specific antigen and serum isoflavone concentrations in men with localized prostate cancer
2010 · GCP group · Men with histologically confirmed low-volume prostate cancer on active surveillance, with rising PSA and no prior prostate cancer treatment
5 g1 year36
The Effects of Soy Isoflavones on Metabolic Status of Patients With Polycystic Ovary Syndrome
2016 · soy isoflavones · Women aged 18–40 with polycystic ovary syndrome diagnosed according to the Rotterdam criteria
50 mg12 weeks35
Soy isoflavones increase preprandial peptide YY (PYY), but have no effect on ghrelin and body weight in healthy postmenopausal women
2006 · Isoflavones · Healthy postmenopausal women; age 59 ± 6 years
50 mg8 weeks34
Marked individual variation in isoflavone metabolism after a soy challenge can modulate the skeletal effect of isoflavones in premenopausal women
2009 · soy group · Healthy premenopausal Korean women aged 30–50 years
120 mg12 weeks32
Seaweed and soy: companion foods in Asian cuisine and their effects on thyroid function in American women
2007 · Soy protein isolate during placebo treatment period · Healthy postmenopausal women, mean age 58 years
2 mg/kg7 days25
The effect of soy isoflavones on non-alcoholic fatty liver disease and the level of fibroblast growth factor-21 and fetuin A
2024 · soy isoflavone group · Adults with non-alcoholic fatty liver disease and grade 2 or higher steatosis; men and women, age 18 or older
100 mg12 weeks25
The effect of soy isoflavones supplementation on metabolic status in patients with non-alcoholic fatty liver disease: a randomized placebo controlled clinical trial
2024 · soy isoflavone group · Adults aged 18 years or older with grade 2 or higher non-alcoholic fatty liver disease; men and women
100 mg12 weeks25
Soy isoflavones improve bone metabolism in postmenopausal Japanese women
2004 · ISO · Women; a subgroup of the study participants was postmenopausal
40 mg4 weeks24
Efficacy and safety of short-term genistein intervention in patients with localized prostate cancer prior to radical prostatectomy: a randomized, placebo-controlled, double-blind Phase 2 clinical trial
2011 · genistein · Patients with localized prostate cancer
30 mg6 weeks23
Moderate intakes of intact soy protein rich in isoflavones compared with ethanol-extracted soy protein increase HDL but do not influence transforming growth factor beta(1) concentrations and hemostatic risk factors for coronary heart disease in healthy subjects
2002 · high-isoflavone diet · Young, healthy, normolipidemic adults; 5 men and 17 women
56 mg17 days22
Moderate intakes of intact soy protein rich in isoflavones compared with ethanol-extracted soy protein increase HDL but do not influence transforming growth factor beta(1) concentrations and hemostatic risk factors for coronary heart disease in healthy subjects
2002 · low-isoflavone diet · Young, healthy, normolipidemic adults; 5 men and 17 women
2 mg17 days22
Soybean isoflavones reduce postmenopausal bone resorption in female Japanese immigrants in Brazil: a ten-week study
2002 · isoflavone-administered group · Healthy postmenopausal Japanese immigrant women living in Brazil
37.3 mg10 weeks20
Soy food supplementation, dietary fat reduction and peripheral blood gene expression in postmenopausal women--a randomized, controlled trial
2011 · SFD group · Healthy postmenopausal women
50 mg8 weeks20
Decreased bone resorption with soy isoflavone supplementation in postmenopausal women
2004 · soy isoflavone supplementation · Postmenopausal women; mean age 70.6 years
110 mg26 weeks19
Soy isoflavones have an antiestrogenic effect and alter mammary promoter hypermethylation in healthy premenopausal women
2009 · high dose · Premenopausal women aged 19–54 without a history of breast cancer
129 mg—19
Modest hormonal effects of soy isoflavones in postmenopausal women
1999 · control · postmenopausal women
0.11 mg/kg93 days18
Modest hormonal effects of soy isoflavones in postmenopausal women
1999 · low-iso · postmenopausal women
1 mg/kg93 days18
Modest hormonal effects of soy isoflavones in postmenopausal women
1999 · high-iso · postmenopausal women
2 mg/kg93 days18
Soy consumption alters endogenous estrogen metabolism in postmenopausal women
2000 · 0.1 mg isoflavones/kg body weight/day control diet · Healthy postmenopausal women
0.1 mg/kg93 days18
Soy consumption alters endogenous estrogen metabolism in postmenopausal women
2000 · 1 mg isoflavones/kg body weight/day diet · Healthy postmenopausal women
1 mg/kg93 days18
Soy consumption alters endogenous estrogen metabolism in postmenopausal women
2000 · 2 mg isoflavones/kg body weight/day diet · Healthy postmenopausal women
2 mg/kg93 days18
Effects of a high daily dose of soy isoflavones on DNA damage, apoptosis, and estrogenic outcomes in healthy postmenopausal women: a phase I clinical trial
2008 · Active group · Healthy, non-obese postmenopausal women; mean age 56.8 years in the active group
600 mg12 weeks18
Effects of a high dose, aglycone-rich soy extract on prostate-specific antigen and serum isoflavone concentrations in men with localized prostate cancer
2010 · Placebo-to-GCP open-label group · Men with histologically confirmed low-volume prostate cancer on active surveillance who had been assigned to placebo in the randomized phase and were eligible for the extension
5 g26 weeks18
Soy isoflavones affect platelet thromboxane A2 receptor density but not plasma lipids in menopausal women
2006 · isoflavone supplement · healthy postmenopausal women
100 mg12 weeks15
Soy isoflavones have an antiestrogenic effect and alter mammary promoter hypermethylation in healthy premenopausal women
2009 · low dose · Premenopausal women aged 19–54 without a history of breast cancer
37.2 mg—15
Genistein effect on cognition in prodromal Alzheimer's disease patients. The GENIAL clinical trial
2022 · genistein · Adults aged 54–75 with prodromal Alzheimer’s disease and amyloid-positive mild cognitive impairment
120 mg360 days14
Soy isoflavones exert modest hormonal effects in premenopausal women
1999 · control diet · 14 premenopausal women
10 mg—14
Soy isoflavones exert modest hormonal effects in premenopausal women
1999 · low isoflavone diet · 14 premenopausal women
64 mg—14
Soy isoflavones exert modest hormonal effects in premenopausal women
1999 · high isoflavone diet · 14 premenopausal women
128 mg—14
Effects of soy isoflavones on estrogen and phytoestrogen metabolism in premenopausal women
1998 · Control diet (0.16 mg/kg/day) · Healthy premenopausal women
0.16 mg/kg100 days12
Effects of soy isoflavones on estrogen and phytoestrogen metabolism in premenopausal women
1998 · 1.01 mg/kg/day isoflavone diet · Healthy premenopausal women
1.01 mg/kg100 days12
Effects of soy isoflavones on estrogen and phytoestrogen metabolism in premenopausal women
1998 · 2.01 mg/kg/day isoflavone diet · Healthy premenopausal women
2.01 mg/kg100 days12
The specific role of isoflavones on estrogen metabolism in premenopausal women
2002 · experimental group · Healthy premenopausal women aged 25–55 years, without breast carcinoma
40 mg12 weeks—
Effects of high- and low-isoflavone soyfoods on blood lipids, oxidized LDL, homocysteine, and blood pressure in hyperlipidemic men and women
2002 · high-isoflavone soyfood diet · Men and postmenopausal women with hyperlipidemia
73 mg30 days—
Effects of high- and low-isoflavone soyfoods on blood lipids, oxidized LDL, homocysteine, and blood pressure in hyperlipidemic men and women
2002 · low-isoflavone soyfood diet · Men and postmenopausal women with hyperlipidemia
10 mg30 days—
Safety, tolerability, and pharmacokinetics of single ascending doses of synthetic genistein (Bonistein) in healthy volunteers
2005 · 30 mg group · healthy volunteers; age and sex not specified
30 mg1 day—
Safety, tolerability, and pharmacokinetics of single ascending doses of synthetic genistein (Bonistein) in healthy volunteers
2005 · 60 mg group · healthy volunteers; age and sex not specified
60 mg1 day—
Safety, tolerability, and pharmacokinetics of single ascending doses of synthetic genistein (Bonistein) in healthy volunteers
2005 · 150 mg group · healthy volunteers; age and sex not specified
150 mg1 day—
Safety, tolerability, and pharmacokinetics of single ascending doses of synthetic genistein (Bonistein) in healthy volunteers
2005 · 300 mg group · healthy volunteers; age and sex not specified
300 mg1 day—
Soy-isoflavone-enriched foods and inflammatory biomarkers of cardiovascular disease risk in postmenopausal women: interactions with genotype and equol production
2005 · isoflavone · Healthy European postmenopausal women
50 mg8 weeks—
Soy isoflavones modulate immune function in healthy postmenopausal women
2006 · supplement · Postmenopausal women aged 50–65 years
70 mg16 weeks—
Pasta naturally enriched with isoflavone aglycons from soy germ reduces serum lipids and improves markers of cardiovascular risk
2007 · soy germ pasta · Adults with hypercholesterolemia
33 mg8 weeks—
Inhibition of prostaglandin synthesis and actions by genistein in human prostate cancer cells and by soy isoflavones in prostate cancer patients
2009 · soy isoflavone supplement (Novasoy) · Men with newly diagnosed, clinically localized prostate adenocarcinoma scheduled for prostatectomy; age not stated
81.6 mg2 weeks—
Soy isoflavones, Mediterranean diet, and physical exercise in postmenopausal women with insulin resistance
2010 · soy isoflavones group · Postmenopausal women with insulin resistance
40 mg2 years—
Soy isoflavones, diet and physical exercise modify serum cytokines in healthy obese postmenopausal women
2011 · soy isoflavones group · Obese postmenopausal women described as healthy
80 mg26 weeks—
Serum IGF-1 concentrations change with soy and seaweed supplements in healthy postmenopausal American women
2011 · soy · Healthy postmenopausal European-American women, mean age 58.4 years; some were breast cancer survivors without current disease
100 g7 days—
Isoflavone supplementation influenced levels of triglyceride and luteunizing hormone in Korean postmenopausal women
2013 · isoflavone group · Korean postmenopausal women with FSH levels higher than 40 IU/ml
70 mg12 weeks—
Effect of whole soy and purified isoflavone daidzein on renal function--a 6-month randomized controlled trial in equol-producing postmenopausal women with prehypertension
2014 · daidzein group · Chinese postmenopausal women with prehypertension who were equol producers
63 mg26 weeks—
Impact of equol-producing capacity and soy-isoflavone profiles of supplements on bone calcium retention in postmenopausal women: a randomized crossover trial
2015 · Genistein-rich soy supplement, 52.85 mg/d · Postmenopausal women prescreened for ability to convert daidzein to equol
52.9 mg50 days—
Impact of equol-producing capacity and soy-isoflavone profiles of supplements on bone calcium retention in postmenopausal women: a randomized crossover trial
2015 · Genistein-rich soy supplement, 113.52 mg/d · Postmenopausal women prescreened for ability to convert daidzein to equol
114 mg50 days—
Impact of equol-producing capacity and soy-isoflavone profiles of supplements on bone calcium retention in postmenopausal women: a randomized crossover trial
2015 · Mixed soy isoflavones in natural ratios, 105.23 mg/d · Postmenopausal women prescreened for ability to convert daidzein to equol
105 mg50 days—
Consumption of soy isoflavone enriched bread in men with prostate cancer is associated with reduced proinflammatory cytokines and immunosuppressive cells
2015 · soy bread · Men with prostate cancer and asymptomatic biochemical recurrence; age range not reported
68 mg8 weeks—
Consumption of soy isoflavone enriched bread in men with prostate cancer is associated with reduced proinflammatory cytokines and immunosuppressive cells
2015 · soy-almond bread · Men with prostate cancer and asymptomatic biochemical recurrence; age range not reported
68 mg8 weeks—
Effect of whole soy and purified daidzein on androgenic hormones in chinese equol-producing post-menopausal women: a six-month randomised, double-blinded and Placebo-Controlled trial
2020 · daidzein group · Chinese equol-producing post-menopausal women aged 45–70 years
63 mg26 weeks—
Effects of soy isoflavones on serum systemic and vascular inflammation markers and oxidative stress in peritoneal dialysis patients: A randomized controlled trial
2020 · isoflavone group · Peritoneal dialysis patients; age and sex not specified
100 mg8 weeks—
Effects of isoflavones on bone turnover markers in peritoneal dialysis patients: a randomized controlled trial
2020 · soy isoflavone group · Peritoneal dialysis patients; age and sex not specified
100 mg8 weeks—
Effects of soy isoflavones on serum lipids and lipoprotein (a) in peritoneal dialysis patients
2020 · isoflavone group · Peritoneal dialysis patients; age and sex not reported
100 mg8 weeks—
Effects of Soy Isoflavones on Glycemic Parameters and Blood Pressure in Peritoneal Dialysis Patients: A Randomized, Double Blind, Placebo-Controlled Trial
2021 · isoflavone group · Peritoneal dialysis patients; age and sex not specified
100 mg8 weeks—
Effects of soy-protein supplementation on epithelial proliferation in the histologically normal human breast
1998 · Soy supplement group · Premenopausal women with benign or malignant breast disease and histologically normal breast epithelium
45 mg2 weeks—
Two-week dietary soy supplementation has an estrogenic effect on normal premenopausal breast
1999 · Dietary soy supplementation · Premenopausal patients with normal breasts
45 mg2 weeks84
Large inter-individual variation in isoflavone plasma concentration limits use of isoflavone intake data for risk assessment
2014 · GD study GEN arm · Postmenopausal women, including equol producers and non-producers
102 mg8 weeks35
Large inter-individual variation in isoflavone plasma concentration limits use of isoflavone intake data for risk assessment
2014 · GD study DAI arm · Postmenopausal women who were equol producers
56 mg8 weeks32
Seaweed and soy: companion foods in Asian cuisine and their effects on thyroid function in American women
2007 · Seaweed treatment period with soy protein isolate · Healthy postmenopausal women, mean age 58 years
2 mg/kg7 weeks25
Large inter-individual variation in isoflavone plasma concentration limits use of isoflavone intake data for risk assessment
2014 · ISO study isoflavone supplement; also used in the GD study DAI arm · Postmenopausal women; all participants in the ISO study and participants in the DAI arm were equol producers
56 mg8 weeks21
Effect of Lactobacillus sporogenes on oral isoflavones bioavailability: single dose pharmacokinetic study in menopausal women
2011 · R (reference formulation) · Menopausal women, mean age 54.3 years, receiving antibiotic therapy
60 mg1 day12
Effect of Lactobacillus sporogenes on oral isoflavones bioavailability: single dose pharmacokinetic study in menopausal women
2011 · E (Estromineral test formulation) · Menopausal women, mean age 54.3 years, receiving antibiotic therapy
60 mg1 day12
Disposition of soy isoflavones in normal human breast tissue
2010 · soy milk · healthy women undergoing breast reduction
50.9 mg5 days11
Disposition of soy isoflavones in normal human breast tissue
2010 · soy supplement · healthy women undergoing breast reduction
68.5 mg5 days10
Effects of dietary intake of soy protein and isoflavones on cardiovascular disease risk factors in high risk, middle-aged men in Scotland
2004 · soy-containing diet group · Men aged 45 to 59 with relatively higher blood pressure and/or total cholesterol levels
80 mg5 weeks—
Plasma phytoestrogens are not altered by probiotic consumption in postmenopausal women with and without a history of breast cancer
2004 · soy + probiotics (S+P) · Postmenopausal women, including breast cancer survivors and controls
26.6 g6 weeks—
Isoflavone pharmacokinetics and metabolism after consumption of a standardized soy and soy-almond bread in men with asymptomatic prostate cancer
2015 · soy bread (SB) · Men aged 52–84 with asymptomatic prostate cancer after primary therapy or during active surveillance and rising PSA
69.8 mg8 weeks—
Isoflavone pharmacokinetics and metabolism after consumption of a standardized soy and soy-almond bread in men with asymptomatic prostate cancer
2015 · soy-almond bread (SAB) · Men aged 52–84 with asymptomatic prostate cancer after primary therapy or during active surveillance and rising PSA
69.4 mg8 weeks—
Effects of the phytoestrogen genistein on some predictors of cardiovascular risk in osteopenic, postmenopausal women: a two-year randomized, double-blind, placebo-controlled study
2007 · genistein group · Osteopenic, postmenopausal women; age range not reported
54 mg2 years198
Equol production changes over time in postmenopausal women
2012 · soy group · Postmenopausal women, predominantly Caucasian; no specific disease stated.
90 mg913 days175
Effect of soy on bone turn-over markers in men with type 2 diabetes and hypogonadism - a randomised controlled study
2017 · SPI group · Men aged 45–75 with type 2 diabetes, low testosterone and normal FSH and LH
66 mg90 days100
Soy isoflavones have a favorable effect on bone loss in Chinese postmenopausal women with lower bone mass: a double-blind, randomized, controlled trial
2003 · mid-dose · Postmenopausal Chinese women aged 48–62 years
40 mg1 year68
Soy isoflavones have a favorable effect on bone loss in Chinese postmenopausal women with lower bone mass: a double-blind, randomized, controlled trial
2003 · high dose · Postmenopausal Chinese women aged 48–62 years
80 mg1 year68
Beneficial effect of soy isoflavones on bone mineral content was modified by years since menopause, body weight, and calcium intake: a double-blind, randomized, controlled trial
2004 · mid-dose · Postmenopausal Chinese women aged 48 to 62 years
40 mg1 year68
Beneficial effect of soy isoflavones on bone mineral content was modified by years since menopause, body weight, and calcium intake: a double-blind, randomized, controlled trial
2004 · high-dose · Postmenopausal Chinese women aged 48 to 62 years
80 mg1 year68
Soy isoflavone supplementation and fasting serum glucose and lipid profile among postmenopausal Chinese women: a double-blind, randomized, placebo-controlled trial
2007 · 40 mg isoflavones · Postmenopausal Chinese women aged 48 to 62 years
40 mg1 year68
Soy isoflavone supplementation and fasting serum glucose and lipid profile among postmenopausal Chinese women: a double-blind, randomized, placebo-controlled trial
2007 · 80 mg isoflavones · Postmenopausal Chinese women aged 48 to 62 years
80 mg1 year68
Endometrial, breast and liver safety of soy isoflavones plus Lactobacillus sporogenes in post-menopausal women
2013 · group E · Healthy postmenopausal women with menopausal symptoms
60 mg1 year65
Soy-tibolone combination - effect on lipids in postmenopausal monkeys and women
2008 · soy powder · Postmenopausal women, mean age 57.7 years, with or without daidzein-to-equol conversion capability, treated with tibolone
112 mg8 weeks40
Soy protein isolates of varying isoflavone content exert minor effects on serum reproductive hormones in healthy young men
2005 · low-isoflavone soy protein isolate (low-iso SPI) · Healthy young men
1.64 mg57 days35
Soy protein isolates of varying isoflavone content exert minor effects on serum reproductive hormones in healthy young men
2005 · high-isoflavone soy protein isolate (high-iso SPI) · Healthy young men
61.7 mg57 days35
The effect of isolated soy protein on plasma biomarkers in elderly men with elevated serum prostate specific antigen
2001 · ISP+ · Elderly men with elevated serum prostate-specific antigen (PSA)
69 mg6 weeks34
The effect of isolated soy protein on plasma biomarkers in elderly men with elevated serum prostate specific antigen
2001 · ISP- · Elderly men with elevated serum prostate-specific antigen (PSA)
3.4 mg6 weeks34
Lycopene and soy isoflavones in the treatment of prostate cancer
2007 · lycopene plus soy isoflavones · Men with prostate cancer and rising serum PSA following local therapy or while on hormone therapy
80 mg26 weeks33
Beneficial effects of soy phytoestrogen intake in postmenopausal women with type 2 diabetes
2002 · phytoestrogen supplementation · Postmenopausal women with diet-controlled type 2 diabetes
132 mg12 weeks32
Effects of high-dose isoflavones on metabolic and inflammatory markers in healthy postmenopausal women
2009 · soy protein / isoflavone group · Postmenopausal women, mean age 57 years, without diabetes or other specified excluded conditions
160 mg12 weeks32
Effect of soy protein foods on low-density lipoprotein oxidation and ex vivo sex hormone receptor activity--a controlled crossover trial
2000 · Test diet · Adults with hyperlipidemia; age and sex not specified
86 mg30 days31
Effect of soy-based breakfast cereal on blood lipids and oxidized low-density lipoprotein
2000 · soy breakfast cereal · Hyperlipidemic men and women; ages and sex distribution not reported
168 mg3 weeks25
Dietary soy containing phytoestrogens does not activate the hemostatic system in postmenopausal women
2005 · soy protein isolate · Healthy postmenopausal women aged 50–75 years
118 mg90 days19
Effect of soy protein supplementation on serum lipoproteins, blood pressure, and menopausal symptoms in perimenopausal women
1999 · 20 g soy protein containing 34 mg of phytoestrogens given in a single dose · Perimenopausal women; age range and specific conditions not stated
34 mg6 weeks—
Effect of soy protein supplementation on serum lipoproteins, blood pressure, and menopausal symptoms in perimenopausal women
1999 · 20 g of soy protein containing 34 mg of phytoestrogens split into two doses · Perimenopausal women; age range and specific conditions not stated
34 mg6 weeks—
A randomized trial comparing the effect of casein with that of soy protein containing varying amounts of isoflavones on plasma concentrations of lipids and lipoproteins
1999 · soy protein containing 3 mg of isoflavones · Healthy men and women with mildly elevated LDL cholesterol, after instruction in a National Cholesterol Education Program Step I diet
3 mg9 weeks—
A randomized trial comparing the effect of casein with that of soy protein containing varying amounts of isoflavones on plasma concentrations of lipids and lipoproteins
1999 · soy protein containing 27 mg of isoflavones · Healthy men and women with mildly elevated LDL cholesterol, after instruction in a National Cholesterol Education Program Step I diet
27 mg9 weeks—
A randomized trial comparing the effect of casein with that of soy protein containing varying amounts of isoflavones on plasma concentrations of lipids and lipoproteins
1999 · soy protein containing 37 mg of isoflavones · Healthy men and women with mildly elevated LDL cholesterol, after instruction in a National Cholesterol Education Program Step I diet
37 mg9 weeks—
A randomized trial comparing the effect of casein with that of soy protein containing varying amounts of isoflavones on plasma concentrations of lipids and lipoproteins
1999 · soy protein containing 62 mg of isoflavones · Healthy men and women with mildly elevated LDL cholesterol, after instruction in a National Cholesterol Education Program Step I diet
62 mg9 weeks—
Probiotic consumption does not enhance the cholesterol-lowering effect of soy in postmenopausal women
2004 · soy protein isolate · postmenopausal women
44 mg6 weeks—
Probiotic consumption does not enhance the cholesterol-lowering effect of soy in postmenopausal women
2004 · soy protein isolate + probiotic capsules · postmenopausal women
44 mg6 weeks—
The hypoglycemic effects of soy isoflavones on postmenopausal women
2004 · isoflavone group · Postmenopausal Taiwanese women
100 mg26 weeks—
The effect of soy consumption on the urinary 2:16-hydroxyestrone ratio in postmenopausal women depends on equol production status but is not influenced by probiotic consumption
2005 · soy protein · Postmenopausal women, including breast cancer survivors and controls
44.4 mg6 weeks—
Isoflavone-rich soy protein isolate suppresses androgen receptor expression without altering estrogen receptor-beta expression or serum hormonal profiles in men at high risk of prostate cancer
2007 · SPI+ (soy protein isolate) · Men at high risk of developing advanced prostate cancer
107 mg26 weeks—
Isoflavone-rich soy protein isolate suppresses androgen receptor expression without altering estrogen receptor-beta expression or serum hormonal profiles in men at high risk of prostate cancer
2007 · SPI- (alcohol-washed soy protein isolate) · Men at high risk of developing advanced prostate cancer
6 mg26 weeks—
Soy protein isolate increases urinary estrogens and the ratio of 2:16alpha-hydroxyestrone in men at high risk of prostate cancer
2007 · isoflavone-rich soy protein isolate (SPI+) · Men at high risk for developing advanced prostate cancer
107 mg26 weeks—
Soy protein isolate increases urinary estrogens and the ratio of 2:16alpha-hydroxyestrone in men at high risk of prostate cancer
2007 · alcohol-washed soy protein isolate (SPI-) · Men at high risk for developing advanced prostate cancer
6 mg26 weeks—
Effects of soy bean on serum paraoxonase 1 activity and lipoproteins in hyperlipidemic postmenopausal women
2009 · soy group · Hypercholesterolemic postmenopausal women
164 mg10 weeks—
Dietary seaweed modifies estrogen and phytoestrogen metabolism in healthy postmenopausal women
2009 · Seaweed schedule, with soy challenge during week 7 · Healthy postmenopausal women
2 mg/kg7 weeks—
[Changes of serum lipids after soy isoflavone and calcium supplementation in postmenopausal Chinese women with different ER-beta genotypes]
2011 · group II · Postmenopausal Chinese women with normal serum lipids and bone loss or osteoporosis
100 mg1 year—
Serum IGF-1 concentrations change with soy and seaweed supplements in healthy postmenopausal American women
2011 · SeaSoy (combination of seaweed and soy) · Healthy postmenopausal European-American women, mean age 58.4 years; some were breast cancer survivors without current disease
100 g7 days—
A phase 2 cancer chemoprevention biomarker trial of isoflavone G-2535 (genistein) in presurgical bladder cancer patients
2012 · G-2535, 300 mg genistein/day · Adults aged 46–97 with an initial or recurrent bladder tumor scheduled for TURBT or cystectomy
450 mg30 days—
A phase 2 cancer chemoprevention biomarker trial of isoflavone G-2535 (genistein) in presurgical bladder cancer patients
2012 · G-2535, 600 mg genistein/day · Adults aged 46–97 with an initial or recurrent bladder tumor scheduled for TURBT or cystectomy
900 mg30 days—
Effect of soybean protein on novel cardiovascular disease risk factors: a randomized controlled trial
2013 · soy protein · Men and women aged 22 years or older with mean systolic blood pressure 120–159 mm Hg and diastolic blood pressure 80–95 mm Hg
89.3 mg8 weeks—
Effect of soy isoflavone supplementation on vascular endothelial function and oxidative stress in postmenopausal women: a community randomized controlled trial
2013 · intervention group · Indonesian postmenopausal women aged 47 to 60 years
100 mg1 year—
Effect of soy isoflavone supplementation on endothelial dysfunction and oxidative stress in equol-producing postmenopausal women
2015 · Intervention group · Postmenopausal Indonesian women aged 47–60 years, stratified by equol-producer status
100 mg26 weeks—
Soy Reduces Bone Turnover Markers in Women During Early Menopause: A Randomized Controlled Trial
2017 · soy protein with isoflavone (SPI) · Women within 2 years after the onset of menopause
66 mg26 weeks—
Effect of Soy in Men With Type 2 Diabetes Mellitus and Subclinical Hypogonadism: A Randomized Controlled Study
2017 · Soy protein with isoflavones (SPI) · Men with type 2 diabetes mellitus and total testosterone ≤12 nmol/L
66 mg90 days—
Novel effects of phytoestrogenic soy isoflavones on serum calcium and chloride in premenopausal women: A 2-year double-blind, randomized, placebo-controlled study
2018 · isoflavone group · Premenopausal women aged 30–42 years with regular monthly menstrual cycles
492 mg2 years—
Evaluation of effect of isoflavone on thyroid economy & autoimmunity in oophorectomised women: a randomised, double-blind, placebo-controlled trial
2011 · isoflavone group · Women younger than 55 years with bilateral oophorectomy and normal baseline TSH
75 mg12 weeks21
Effects of soy protein isolate and moderate exercise on bone turnover and bone mineral density in postmenopausal women
2007 · SPI + EX · Postmenopausal women aged 50–65 years
91.2 mg274 days11
Effects of soy protein isolate and moderate exercise on bone turnover and bone mineral density in postmenopausal women
2007 · SPI · Postmenopausal women aged 50–65 years
91.2 mg274 days10
The effect of soy consumption on the urinary 2:16-hydroxyestrone ratio in postmenopausal women depends on equol production status but is not influenced by probiotic consumption
2005 · soy protein + probiotics · Postmenopausal women, including breast cancer survivors and controls
44.4 mg6 weeks—
A mild favorable effect of soy protein with isoflavones on body composition--a 6-month double-blind randomized placebo-controlled trial among Chinese postmenopausal women
2010 · Iso group · Chinese postmenopausal women with mild hyperglycemia; age range not reported
100 mg26 weeks—
Contribution of serum inflammatory markers to changes in bone mineral content and density in postmenopausal women: a 1-year investigation
2010 · low-dose soy isoflavones · Healthy postmenopausal women aged 45.8–65.0 years, selected as at risk because they were less than 10 years since their last menses
80 mg3 years—
Contribution of serum inflammatory markers to changes in bone mineral content and density in postmenopausal women: a 1-year investigation
2010 · high-dose soy isoflavones · Healthy postmenopausal women aged 45.8–65.0 years, selected as at risk because they were less than 10 years since their last menses
120 mg3 years—